About Blucrab Pharma Private Limited
Data last updated:
Blucrab Pharma Private Limited is a private limited company based in Vastral, Gujarat, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 02 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2016PTC091794. Its GSTIN is 09AAGCB7086E1ZH (Uttar Pradesh).
The company has an authorised share capital of ₹3 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Meenakshi Yadav and Ruby Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 100 Manhar Park (Madhav Park Pa – 2 ), Vastral, Gujarat, India – 382418.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.1 Cr, a decline of 28% compared to the previous year. For the same year it recorded a net profit of ₹1.02 Lakh (net margin 0.9%) and EBITDA of ₹1.38 Lakh (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 26% over five years.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website blucrabpharma.business.site.
Company details
Contact details
Blucrab Pharma Private Limited's registered office is in Vastral, Gujarat. Its website is blucrabpharma.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address100 Manhar Park (Madhav Park Pa – 2 ), Vastral, Gujarat, India – 382418
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Blucrab Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Blucrab Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Blucrab Pharma Private Limited, buy the company report.
Financials of Blucrab Pharma Private Limited
FY 2025 filings availableBlucrab Pharma Private Limited reported revenue of ₹1.1 Cr (down 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 28% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 26%. EBITDA fell 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.38 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Blucrab Pharma Private Limited, buy the company report.
Board of directors of Blucrab Pharma Private Limited
Blucrab Pharma has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meenakshi Yadav | Director | 30 Sep 2023 | 3 Years 0 Months | Current |
| Amit Kumar Tripathi | Additional Director | 14 Mar 2019 | 7 Years 7 Months | Current |
| Ruby Tripathi | Director | 02 May 2016 | 10 Years 5 Months | Current |
| Rama Shankar Yadav | Director | 02 May 2016 | 10 Years 5 Months | Current |
Peer comparison
Blucrab Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dynamic Infra and Services (India) Private Limited (OPC) | ₹1.11 Cr (FY 2023) | -2.0% | Patna, Bihar, India | |||
| Bioserve Scientific Solutions Private Limited | ₹1.1 Cr (FY 2024) | 259.0% | Delhi, India | |||
| Biolab Equipt Private Limited | ₹1.1 Cr (FY 2022) | -68.0% | Kolkata, West Bengal, India | |||
| Machdeal India Private Limited | ₹1.1 Cr (FY 2025) | 344.0% | Saoner, Maharashtra, India | |||
| Iris Healthcare Technologies Private Limited | ₹1.1 Cr (FY 2025) | -89.0% | Mumbai, Maharashtra, India | |||
| Blucrab Pharma Private Limitedthis company | ₹1.1 Cr (FY 2025) | ₹1.02 Lakh | 0.9% | -28.0% | Vastral, Gujarat, India |
To see the full peer comparison of Blucrab Pharma Private Limited, buy the company report.
Auditor
Blucrab Pharma Private Limited is audited by SAJAL GUPTA & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SAJAL GUPTA & CO | FY 2020 | 021983C |
Shareholding
The shareholding of Blucrab Pharma Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Blucrab Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Blucrab Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Blucrab Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Blucrab Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCB7086E1ZH | Uttar Pradesh | Active | 09 Jul 2019 |
To see the full GST registrations and return filing status of Blucrab Pharma Private Limited, buy the company report.
Recent activity
Blucrab Pharma Private Limited has 7 board changes on record since 2016: 4 appointments and 3 cessations. The latest: Abhishek Kumar Pandey ceased to be Director on 15 May 2024.
Frequently asked questions
Blucrab Pharma is an active private limited company based in Vastral, Gujarat, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 02 May 2016 (10+ years old) and is registered under CIN U74999GJ2016PTC091794.
Blucrab Pharma has 4 current directors:
- Meenakshi Yadav - Director
- Amit Kumar Tripathi - Additional Director
- Ruby Tripathi - Director
- Rama Shankar Yadav - Director
The latest financial statements of Blucrab Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Blucrab Pharma is 09AAGCB7086E1ZH, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Blucrab Pharma is U74999GJ2016PTC091794. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Blucrab Pharma was incorporated on 02 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Blucrab Pharma by revenue are Dynamic Infra and Services (India) Private Limited (OPC), Bioserve Scientific Solutions Private Limited, Biolab Equipt Private Limited, Machdeal India Private Limited, Iris Healthcare Technologies Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Abhishek Kumar Pandey ceased to be Director on 15 May 2024. Markanday Narayan Panday ceased to be Director on 15 May 2024. Meenakshi Yadav was appointed as Director on 30 Sep 2023. Blucrab Pharma has 7 board changes on record in total.
Blucrab Pharma can be reached through the website blucrabpharma.business.site. Its registered office is in Vastral, Gujarat, India.
The registered office of Blucrab Pharma is at 100 Manhar Park Madhav Park Pa – 2 , Vastral, Gujarat, India – 382418.
Blucrab Pharma operates in the healthcare industry, in the medical equipment retail and distribution segment.